Daewon Pharmaceutical Co. Ltd. (003220) — Free Cash Flow Generation Index
Daewon Pharmaceutical Co. Ltd. (003220) has a Free Cash Flow Generation Index of -0.22x as of March 2026. Free cash flow of ₩-2.05 Billion represents 0% of operating cash flow (₩9.21 Billion). Check 003220 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Daewon Pharmaceutical Co. Ltd. Free Cash Flow Generation Index (2011–2025)
Historical FCF Generation Index trend for Daewon Pharmaceutical Co. Ltd. across 15 annual periods. Explore how much does Daewon Pharmaceutical Co. Ltd. reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Daewon Pharmaceutical Co. Ltd. (2011–2025)
Year-by-year Free Cash Flow Generation Index for Daewon Pharmaceutical Co. Ltd.. For the full cash flow conversion analysis, see cash flow conversion of Daewon Pharmaceutical Co. Ltd..
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | ₩181.86 Million | ₩42.31 Billion | ₩42.13 Billion | ▲ +100.5% |
| 2024 | -0.78x | ₩-23.55 Billion | ₩30.04 Billion | ₩53.58 Billion | ▼ -230.3% |
| 2023 | 0.60x | ₩31.12 Billion | ₩51.73 Billion | ₩20.61 Billion | ▲ +0.4% |
| 2022 | 0.60x | ₩19.96 Billion | ₩33.33 Billion | ₩13.37 Billion | ▲ +25.4% |
| 2021 | 0.48x | ₩10.71 Billion | ₩22.41 Billion | ₩4.10 Billion | ▲ +30.0% |
| 2020 | 0.37x | ₩9.17 Billion | ₩24.95 Billion | ₩11.35 Billion | ▲ +300.3% |
| 2019 | -0.18x | ₩-5.68 Billion | ₩30.97 Billion | ₩33.03 Billion | ▼ -188.0% |
| 2018 | -0.06x | ₩-2.55 Billion | ₩40.03 Billion | ₩40.82 Billion | ▲ +98.0% |
| 2017 | -3.15x | ₩-13.46 Billion | ₩4.27 Billion | ₩14.71 Billion | ▼ -258.6% |
| 2016 | 1.99x | ₩41.36 Billion | ₩20.79 Billion | ₩20.57 Billion | ▲ +12.6% |
| 2015 | 1.77x | ₩45.62 Billion | ₩25.82 Billion | ₩19.80 Billion | ▼ -7.4% |
| 2014 | 1.91x | ₩33.28 Billion | ₩17.45 Billion | ₩15.84 Billion | ▲ +6.0% |
| 2013 | 1.80x | ₩22.17 Billion | ₩12.32 Billion | ₩9.85 Billion | ▲ +45.2% |
| 2012 | 1.24x | ₩17.13 Billion | ₩13.83 Billion | ₩3.30 Billion | ▼ -21.0% |
| 2011 | 1.57x | ₩28.12 Billion | ₩17.93 Billion | ₩10.19 Billion | — |